Reuters logo
BRIEF-C. R. Bard receives FDA premarket approval of the Lutonix
August 28, 2017 / 1:17 PM / a month ago

BRIEF-C. R. Bard receives FDA premarket approval of the Lutonix

Aug 28 (Reuters) - C R Bard Inc-

* C. R. Bard receives fda premarket approval of the lutonix® 035 drug coated balloon as the first and only DCB for the treatment of patients with dysfunctional av fistulae

* C R Bard Inc- ‍lutonix® 035 drug coated balloon pta catheter is now available for sale in United States​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below